LIFETECH SCI.DL-00000125 (F:81X) — Stock Price
LIFETECH SCI.DL-00000125 (F:81X) is currently trading at €0.15 EUR, up 4.83% today. Over the past 52 weeks, shares have ranged between €0.14 and €0.24. This page tracks LIFETECH SCI.DL-00000125's live share price on the F exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see 81X market cap.
LIFETECH SCI.DL-00000125 (81X) Stock Price Chart — Daily History & Trading Volume
The chart below tracks LIFETECH SCI.DL-00000125's daily closing share price and trading volume on the F exchange over the past year, giving a clear view of recent price momentum and liquidity.
LIFETECH SCI.DL-00000125 Income Statement — Revenue, Profit & Earnings by Year
LIFETECH SCI.DL-00000125's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | €1.37 Billion | €1.30 Billion | €1.27 Billion | €1.10 Billion | €925.33 Million |
| Cost of Revenue | €350.67 Million | €322.26 Million | €271.54 Million | €223.38 Million | €177.80 Million |
| Gross Profit | €1.02 Billion | €981.43 Million | €995.64 Million | €873.93 Million | €747.53 Million |
| Research & Development | €242.66 Million | €302.92 Million | €297.92 Million | €208.48 Million | €145.89 Million |
| SG&A | €607.13 Million | €504.20 Million | €414.59 Million | €347.70 Million | €291.18 Million |
| Total Operating Expenses | €1.19 Billion | €1.12 Billion | €972.72 Million | €754.33 Million | €598.66 Million |
| Operating Income | €175.88 Million | €180.68 Million | €294.46 Million | €342.98 Million | €326.67 Million |
| EBITDA | — | — | — | — | — |
| EBIT | — | — | — | — | — |
| Interest Expense | €210.00K | €1.89 Million | €722.00K | €632.00K | €2.61 Million |
| Income Before Tax | €191.45 Million | €199.00 Million | €175.58 Million | €378.05 Million | €332.93 Million |
| Income Tax Expense | — | — | — | — | — |
| Net Income | €147.83 Million | €222.39 Million | €263.24 Million | €325.34 Million | €292.47 Million |
LIFETECH SCI.DL-00000125 Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes LIFETECH SCI.DL-00000125's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | €5.01 Billion | €4.90 Billion | €4.70 Billion | €3.69 Billion | €3.18 Billion |
| Total Current Assets | €2.33 Billion | €2.33 Billion | €2.23 Billion | €1.40 Billion | €1.84 Billion |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | €430.78 Million | €516.13 Million | €200.00 Million | — | €357.11 Million |
| Net Receivables | €161.80 Million | €136.69 Million | €105.19 Million | €137.09 Million | €110.04 Million |
| Inventory | €444.90 Million | €532.40 Million | €483.61 Million | €241.41 Million | €129.29 Million |
| Property, Plant & Equipment | — | — | — | — | — |
| Goodwill | — | — | — | — | — |
| Total Liabilities | €1.54 Billion | €1.42 Billion | €1.37 Billion | €769.05 Million | €653.61 Million |
| Total Current Liabilities | €1.48 Billion | €815.64 Million | €770.14 Million | €584.74 Million | €481.91 Million |
| Long-term Debt | — | — | — | — | — |
| Net Debt | — | — | — | — | — |
| Total Stockholder Equity | €3.51 Billion | €3.49 Billion | €3.37 Billion | €2.90 Billion | €2.50 Billion |
| Retained Earnings | €2.02 Billion | €1.87 Billion | €1.65 Billion | €1.39 Billion | €1.06 Billion |
LIFETECH SCI.DL-00000125 Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how LIFETECH SCI.DL-00000125 generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | €549.28 Million | €321.46 Million | €418.05 Million | €388.32 Million | €441.09 Million |
| Capital Expenditures | €150.25 Million | €283.00 Million | €292.69 Million | €335.47 Million | €343.29 Million |
| Free Cash Flow | €399.03 Million | €38.46 Million | €125.36 Million | €52.84 Million | €97.81 Million |
| Investing Cash Flow | — | — | — | — | — |
| Financing Cash Flow | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | €223.29 Million | €133.38 Million | €112.83 Million | €62.72 Million | €19.73 Million |
| Depreciation | €103.09 Million | €88.00 Million | €77.16 Million | €67.11 Million | €62.05 Million |
| Change in Cash | €52.12 Million | €-313.04 Million | €146.88 Million | €-285.35 Million | €145.72 Million |
LIFETECH SCI.DL-00000125 Earnings History — EPS Actual vs. Analyst Estimates
Track LIFETECH SCI.DL-00000125's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
Earnings history is not currently available for LIFETECH SCI.DL-00000125.